Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $19.75 Analyst target: $19.75 Upside: 0.00%
Silence Therapeutics plc, a biotechnology company, is focused on the discovery and development of new ribonucleic acid (RNA) therapies in hematology, cardiovascular, and other rare and metabolic indications. The company is headquartered in London, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.